President and also chief executive officer
Søren Tulstrup has a wide and also extensive history as elderly exec in the global biopharma sector. Just recently, he worked as CEO of Vifor Pharma AG (VTX: VIFN), a Glattbrugg, Switzerland-based global pharmaceutical firm with a market-leading setting within persistent kidney disease, annual sales of approximately USD 1 billion and also 2,000 staff members. Before joining Vifor Pharma, he served as Elderly Vice Head Of State, Global Franchise Head, MPS at County Pharmaceuticals, securing strong market performance of Elaprase (INN: Idursulfase), an enzyme-based therapy of the rare condition Seeker disorder. Søren has likewise functioned as CEO of Santaris Pharma A/S, currently part of Roche, a leading professional stage biopharmaceutical business establishing RNA-targeted medicines for numerous therapeutic areas consisting of cancer and also unusual genetic diseases. Moreover, Søren has actually served in numerous elderly business roles within Merck & Co., Inc. as well as Sandoz Pharma AG (Novartis) and also he holds a Master of Science, Business Economics as well as Service Management from Copenhagen Company Institution. Born 1965.
Share civil liberties (max *): 51,389
* The possible entitlement of share legal rights with the incentive program LTIP2018 is the potential optimum number. Share right allowance could be reduced or zero relying on the share rate advancement.
Vice Head Of State Global Business Development
Emanuel signed up with Hansa Medical in 2007 counting greater than 15 years of functional experience from Scandinavian Pharma as well as Biotech market (Biolin Scientific, Polypeptide Labs as well as Hansa Medical) serving as Business Analyst, Analytical Drug store and also start-up chief executive officer. Emanuel holds a M.Sc. in Design Physics (biophysics core) from Lund University as well as the University of The Golden State at Santa Barbara.
Shareholding: Share civil liberties (max *): 20,000
* The feasible privilege of share rights with the motivation program LTIP2016 is the prospective maximum number. Share right appropriation could be lower or absolutely no depending on the share price development.
Vice Head Of State, Corporate Approach
Max signed up with Hansa Medical in 2017. He has wide corporate development history and had actually formerly collaborated with business financing at Biovitrum/SOBI in the position of Supervisor Mergers & Acquisitions. Before joining Hansa Medical, Max collaborated with strategy and business growth at Envirotainer as the Worldwide Product Or Services Development Manager. Max holds an M.Sc. in Biotechnology from the Royal Institute of Technology.
- Shareholding: 3,100
- Share rights (max *): 20,201
* The possible privilege of share rights via the incentive program LTIP2016 and also LTIP2018 is the prospective maximum number. Share right allowance could be reduced or no depending on the share cost growth.
Vice President, Financing & management
Eva-Maria signed up with Hansa Medical in 2015 and brings lengthy as well as wide experience within money to the business. She has held settings both as Chief Accountant and CFO as well as operated in international companies such as Kemira Kemi Abdominal, Johns Manville Abdominal within the Berkshire Hathaway team and Procordia Food AB. She has actually additionally been responsible for applying brand-new financial systems as well as plans, as well as for IT. Eva-Maria holds a Master of Science in Company as well as Economics from Lund College.
- Shareholding: 8,000
- Share civil liberties (max *): 20,000
* The possible privilege of share civil liberties with the reward program LTIP2016 is the potential maximum number. Share right allotment could be reduced or absolutely no depending upon the share rate growth.
Dr. Christian Kjellman
Senior Vice President, R & D
Christian joined Hansa Medical in 2008 after serving at BioInvent abdominal as Senior citizen Scientist concentrating on novel target evaluation as well as antibody innovation. Before that, he worked as Head of Research study at the biopharmaceutical growth firm Cartela abdominal muscle, mostly concentrating on novel medication target evaluation. He has comprehensive research experience in cell- as well as molecular biology and also as an Aide Professor in Molecular Genetics at Lund University. Christian holds a M.Sc. in Chemical Biology as well as a Ph.D. in Tumor Immunology from Lund College.
- Share civil liberties (max *): 54,084
* The feasible entitlement of share civil liberties through the reward program LTIP2016 and LTIP2018 is the possible maximum number. Share right appropriation could be lower or absolutely no relying on the share cost growth.
Henk Doude van Troostwijk
Vice President, Commercial Workflow.
Henk has considerable administration experience in sales and also marketing in the areas of transplant and orphan drugs. Prior to joining Hansa Medical in 2016, Henk worked as General Manager of European Commercial Procedures and also Emerging Markets at Raptor Pharmaceuticals, an orphan condition concentrated global biopharma business based in the United States. Before that, he held the placement of Service Device Supervisor Oncology and also Transplant at Genzyme Europe BV. Henk holds an MBA from Henley Management University at the College of Analysis, UK.
- Shareholding: –
- Share civil liberties (max *): 22,100
* The possible entitlement of share rights through the motivation program LTIP2016 as well as LTIP2018 is the potential maximum number. Share right appropriation could be reduced or no relying on the share price development.
Vice President Regulatory Affairs
Karin signed up with Hansa in 2016. She has a lengthy experience from working within Regulatory Affairs, originally at AstraZeneca, and has actually dealt with EU and also US jobs in all scientific trial stages with enrollment approximately marketing stage. Karin has actually held the position as Head of Regulatory Matters at Energetic Biotech as well as at ClinicalDataCare. She has additionally been working as an independent regulatory specialist. Karin holds a M.Sc. in Pharmacy from Uppsala University.
- Shareholding: –
- Share civil liberties (max *): 14,504
* Karin is expert because 2016. Entitled to LTIP2018 upon employment. The possible privilege of share civil liberties through the reward program LTIP2018 is the prospective maximum number. Share right allotment could be lower or absolutely no depending on the share cost advancement.
Vice Head Of State, Global Medical Matters
Vincenza holds more than twenty years of global, life sciences industry experience in clinical events, scientific advancement and business leadership roles, consisting of deep experience in hair transplant and also orphan illness. Before joining Hansa Medical in 2018, Vincenza constructed as well as led the global medical events work at Veloxis Pharmaceuticals, a specialized pharmaceutical company focused on hair transplant. Formerly, she spent over a years at Hoffmann- La Roche in the United States in medicine exploration, medical advancement as well as industrial duties within immunology and transplant. She has likewise held a commercial management duty at United States specialty pharma firm Enzon Pharmaceuticals, which was concentrated on oncology. Ms. Nigro holds an MBA degree from Massachusetts Institute of Innovation (MIT).
- Share legal rights (max *): 7,042.
* The possible privilege of share rights via the incentive program LTIP2016 and LTIP2018 is the possible maximum number. Share right appropriation could be lower or absolutely no depending upon the share cost growth.
Anne Säfström Lanner.
Vice President, Global HR.
Anne joined Hansa Medical in 2019, after having actually served at European Spallation Resource (ESS), a joint European multi-disciplinary research facility as well as at Cellavision, a supplier of electronic remedies for medical microscopy within hematology. She has actually held placements both as Head of HR, Head of Resourcing, Human Resources Manager & Replacement Head of human resources and has considerable experience from expanding start-up global firms. Anne holds a Bachelor of Social Science in Human Resource Administration, focusing in business development & leadership, from Lund University.
- Shareholding: 600.
Elderly Vice President, Principal Financial Officer.
Donato signed up with Hansa Biopharma in 2019, and also brings greater than two decades of pharmaceutical market experience in global settings, consisting of tactical finance, financier relations and also worldwide resources markets purchases to the firm. Prior to signing up with Hansa, Donato functioned as Chief Financial Officer at Basilea Pharmaceutica AG. Donato holds a degree in Information Technology from the Swiss BBT (Bundesamt für Berufsbildung und Technologie) and also a master’s degree in organization management from the Hochschule für Wirtschaft und Umwelt Nürtingen-Geislingen.